Cell door: EMA grants ATMP classification to CELTIC-19
Advanced Therapy Medicinal Product classification for Ixaka Ltd’s chemically encapsulated lentiviral vector
Read More
Tag: ATMP
GSK to leverage the Cell and Gene Therapy Catapult’s facility in Stevenage
British drugmaker to expand its clinical manufacturing capacity for cell and gene therapy
Read More
Cell and Gene Therapy Catapult addresses sector skills gap
The Cell and Gene Therapy (CGT) Catapult has launched the first Advanced Therapy Medicinal Products (ATMP) focused apprenticeship programme, developed in partnership with The Medicine Manufacturing Industry Partnership (MMIP).
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
